This content is machine translated Multiple sclerosis Glatiramer acetate now also approved for use in the breastfeeding period Glatiramer acetate 20 mg/ml and 40 mg/ml, indicated for the treatment of relapsing forms of multiple sclerosis (RMS) in Europe, has updated its SmPC. The product is now approved for…
